Neil Kumar
Director; Director, Chief Executive Officer · 15 filings · Latest: Sep 17, 2026
BridgeBio Oncology Therapeutics, Inc.
BridgeBio Pharma, Inc.
Maze Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BBIO | Neil Kumar | Director, Chief Executive Officer | Sep 17, 2026 | Sale | $69.08 | 10,000 | $690.8K | 495,686 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Aug 19, 2026 | Sale | $84.03 | 10,000 | $840.3K | 505,686 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Aug 18, 2026 | Sale | $82.53 | 34,980 | $2.9M | 243,327 | |
BBIO | KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 | — | Aug 19, 2026 | Proposed Sale | $82.98 | 30,000 | $2.5M | — | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Aug 16, 2026 | Option Exercise | — | 71,217 | — | 314,544 | |
BBIO | NEIL KUMAR | — | Aug 18, 2026 | Proposed Sale | $79.89 | 34,980 | $2.8M | — | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Jun 5, 2026 | Sale | $67.88 | 40,000 | $2.7M | 4,318,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Jun 4, 2026 | Sale | $67.46 | 40,000 | $2.7M | 4,338,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | May 21, 2026 | Sale | $69.44 | 26,103 | $1.8M | 243,327 | |
BBIO | NEIL KUMAR | — | May 21, 2026 | Proposed Sale | $68.22 | 26,103 | $1.8M | — | |
BBIO | Neil Kumar | Director, Chief Executive Officer | May 16, 2026 | Option Exercise | — | 71,215 | — | 305,666 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | May 8, 2026 | Sale | $66.91 | 40,000 | $2.7M | 4,358,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | May 7, 2026 | Sale | $67.90 | 40,000 | $2.7M | 4,378,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Apr 10, 2026 | Sale | $74.60 | 40,000 | $3.0M | 4,398,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Apr 9, 2026 | Sale | $74.62 | 40,000 | $3.0M | 4,418,447 | |
BBIO | KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 | — | Apr 9, 2026 | Proposed Sale | $74.14 | 120,000 | $8.9M | — | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Mar 13, 2026 | Sale | $68.80 | 40,000 | $2.8M | 4,438,447 | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Mar 12, 2026 | Sale | $68.73 | 40,000 | $2.7M | 4,458,447 | |
BBIO | KUMAR HALDEA FAMILY IRREVOCABLE TRUST | — | Mar 13, 2026 | Proposed Sale | $67.98 | 140,000 | $9.5M | — | |
BBIO | Neil Kumar | Director, Chief Executive Officer | Feb 19, 2026 | Sale | $71.39 | 28,053 | $2.0M | 234,451 |
Page 1 of 2
Next →